Convolutional neural network-based segmentation can help in assessing the substantia nigra in neuromelanin MRI

Fully Automatic Brain Tumor Segmentation using End-to-End Incremental Deep Neural Networks in MRI images

(2018) Mostefa Ben naceur et al.   COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE

Fully convolutional network ensembles for white matter hyperintensities segmentation in MR images

(2018) Hongwei Li et al.   NEUROIMAGE

Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

(2018) Spencer L James et al.   LANCET

AnatomyNet: Deep learning for fast and fully automated whole-volume segmentation of head and neck anatomy

(2018) Wentao Zhu et al.   MEDICAL PHYSICS

Life span pigmentation changes of the substantia nigra detected by neuromelanin-sensitive MRI

(2018) Yue Xing et al.   MOVEMENT DISORDERS

Neuromelanin MRI is useful for monitoring motor complications in Parkinson’s and PARK2 disease

(2017) Taku Hatano et al.   JOURNAL OF NEURAL TRANSMISSION

In Vivo Assessment of Brainstem Depigmentation in Parkinson Disease: Potential as a Severity Marker for Multicenter Studies

(2017) Stefan T. Schwarz et al.   RADIOLOGY

Substantia Nigra Neuromelanin as an Imaging Biomarker of Disease Progression in Parkinson’s Disease

(2017) Margherita Fabbri et al.   Journal of Parkinsons Disease

Contrast mechanisms associated with neuromelanin-MRI

(2016) Paula Trujillo et al.   MAGNETIC RESONANCE IN MEDICINE

Current disease modifying approaches to treat Parkinson’s disease

(2015) Dan Lindholm et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Neurite orientation dispersion and density imaging in the substantia nigra in idiopathic Parkinson disease

(2015) Koji Kamagata et al.   EUROPEAN RADIOLOGY

Automated Neuromelanin Imaging as a Diagnostic Biomarker for Parkinson's Disease

(2015) Gabriel Castellanos et al.   MOVEMENT DISORDERS

MDS clinical diagnostic criteria for Parkinson's disease

(2015) Ronald B. Postuma et al.   MOVEMENT DISORDERS

Deep learning

(2015) Yann LeCun et al.   NATURE

Loss of dopaminergic nigrostriatal neurons accounts for the motivational and affective deficits in Parkinson’s disease

(2013) G Drui et al.   MOLECULAR PSYCHIATRY

3D neuromelanin-sensitive magnetic resonance imaging with semi-automated volume measurement of the substantia nigra pars compacta for diagnosis of Parkinson’s disease

(2013) Kimihiro Ogisu et al.   NEURORADIOLOGY

Changes in substantia nigra and locus coeruleus in patients with early-stage Parkinson's disease using neuromelanin-sensitive MR imaging

(2013) Chigumi Ohtsuka et al.   NEUROSCIENCE LETTERS

EFNS/MDS-ES recommendations for the diagnosis of Parkinson's disease

(2012) A. Berardelli et al.   EUROPEAN JOURNAL OF NEUROLOGY

Neuromelanin magnetic resonance imaging of nigral volume loss in patients with Parkinson’s disease

(2011) Kenichi Kashihara et al.   JOURNAL OF CLINICAL NEUROSCIENCE

T1-Weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson's disease

(2011) Stefan T. Schwarz et al.   MOVEMENT DISORDERS

Clinical progression in Parkinson disease and the neurobiology of axons

(2010) Hsiao-Chun Cheng et al.   ANNALS OF NEUROLOGY

Multi-atlas based segmentation of brain images: Atlas selection and its effect on accuracy

(2009) P. Aljabar et al.   NEUROIMAGE

Neuromelanin Activates Microglia and Induces Degeneration of Dopaminergic Neurons: Implications for Progression of Parkinson’s Disease

(2009) Wei Zhang et al.   NEUROTOXICITY RESEARCH